temozolomide has been researched along with Myeloproliferative Disorders in 1 studies
Myeloproliferative Disorders: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Genotyping of putative determinants of temozolomide (TMZ)-induced life-threatening bone marrow suppression was performed in two patients with glioma treated with adjuvant TMZ and radiation therapy." | 3.77 | Temozolomide-induced severe myelosuppression: analysis of clinically associated polymorphisms in two patients. ( Berg, A; Kolesar, J; Mehta, M; Petrich, RJ; Steen, P; Sylvester, RK; Tate, JM, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sylvester, RK | 1 |
| Steen, P | 1 |
| Tate, JM | 1 |
| Mehta, M | 1 |
| Petrich, RJ | 1 |
| Berg, A | 1 |
| Kolesar, J | 1 |
1 other study available for temozolomide and Myeloproliferative Disorders
| Article | Year |
|---|---|
Temozolomide-induced severe myelosuppression: analysis of clinically associated polymorphisms in two patients.
Topics: Adult; Antineoplastic Agents, Alkylating; ATP Binding Cassette Transporter, Subfamily B; ATP Binding | 2011 |